Aims & Scope
Scope of the Journal
Research published in Cellular & Molecular Intelligence spans all areas of pharmaceutical and therapeutic inquiry, including medicinal chemistry, pharmacology, pharmaceutics, pharmaceutical analysis, experimental and clinical medicine, biotechnology, microbiology, immunology, and systems pharmacology.
The journal seeks to promote international collaboration, encourage interdisciplinary integration, and accelerate the translation of molecular intelligence into human health advancement.
CMI reflects the accelerating convergence of computational and biological innovation that is transforming modern medicine. We focus on studies that address fundamental mechanisms of disease pathogenesis and use data-driven or AI-assisted strategies to guide discovery and therapeutic design. Submissions are encouraged in the following core areas:
1. Computational & Artificial Intelligence in Biology
• Foundation Models for Biology: Large-scale language models for proteins, RNA, and genomic architecture.
• Agentic AI & Autonomous Labs: AI systems that autonomously design and execute wet-lab experiments.
• Drug Design and Discovery: Generative AI for molecule synthesis, target prediction, high-throughput screening, ADME/Tox studies, combinatorial chemistry, and ligand interaction and validation.
• Molecular Pharmacology: Genomics, proteomics, pharmacogenomics, and biomarker discovery.
2. Cellular Decision-Making & Intelligence
• Biological Logic Gates: How cells integrate complex cues to choose between apoptosis, proliferation, or differentiation.
• Immune Intelligence: Molecular foundations of immune memory and adaptive responses.
• Neuro-Molecular Networks: Intelligence at the interface of neuronal signaling and molecular regulation.
3. Systems Biology & Multi-Omics Integration
• Digital Twins: Multi-scale modeling of cells and organs to predict disease and treatment response.
• Spatial Intelligence: Spatial omics revealing how tissue architecture shapes cellular function.
• Network Pharmacology: Deep learning approaches to map protein-protein and gene-regulatory networks.
4. Programmable & Synthetic Therapeutics
• CRISPR & Beyond: AI-optimized genome and epigenome editing technologies.
• Molecular Robotics: Smart nanosystems for site-specific delivery of therapeutic payloads.
• Synthetic Circuitry: Engineered biological “computers” for diagnostic and therapeutic functions.
Diseases and Application Areas
CMI welcomes research addressing all human diseases, from rare genetic and developmental disorders to major global health challenges. Areas of interest include:
• Gene and cell therapies
• Clinical and functional genomics
• Regenerative and high-definition medicine
• Early disease diagnosis and precision health
• Microbiome and environmental health
• Cancer, cardiovascular, metabolic, and autoimmune diseases
• Aging and neurodegenerative diseases
• Infectious and inflammatory disorders
Article Types
The journal accepts several categories of manuscripts.
Original Research Articles
Full-length reports describing novel experimental or clinical findings.
Review Articles
Comprehensive and critical reviews summarizing current knowledge in a specific field.
Short Communications
Brief reports presenting important preliminary findings.
Case Reports
Clinical observations offering novel insights into disease or treatment.
Methods and Protocols
Descriptions of new techniques or improved experimental methodologies.
Letters to the Editor
Comments or discussions related to previously published articles.